RecruitingNot ApplicableNCT07292779

A Prospective Clinical Investigation of DMFI150 for Treating Nasolabial Folds

A Prospective, Clinical Investigation to Evaluate the Performance and Safety of DMFI150 for the Treatment of Nasolabial Folds

Sponsor

Samyang Biopharmaceuticals Corporation

Enrollment

30 participants

Start Date

Nov 24, 2025

Study Type

INTERVENTIONAL

Conditions

Nasolabial Folds, Wrinkles

Summary

This is a prospective clinical investigation designed to evaluate the performance and safety of DMFI150 for the treatment of nasolabial folds. 30 adult participants will receive a single treatment with the investigational device. The study will assess wrinkle severity using validated aesthetic evaluation scales, as well as overall safety.

Eligibility

Min Age: 18 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called DMFI150 for people with nasolabial folds, wrinkles. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 70 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEDMFI150

Injection of DMFI150 for nasolabial folds.

Locations(1)

Ocean Clinic

Marbella, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07292779

Related Trials

A Prospective Clinical Investigation of DMFI300 for Treating Nasolabial Folds

NCT074672391 location